At the final analysis , there was no difference in PFS ( hazard ratio -LSB- HR -RSB- of placebo to lapatinib , @ ; @ % CI , @ to @ ; P = @ ) ; median PFS was @ months for fulvestrant plus lapatinib versus @ months for fulvestrant plus placebo .